Pharmaceutical Ethics serves as the guiding moral foundation that shapes the conduct and decision-making within the pharmaceutical industry. It is a crucial framework designed to ensure that drug development, production, and distribution align with the principles of patient welfare and societal well-being.
At its core, pharmaceutical ethics underscores the significance of placing patient interests above commercial considerations. This involves promoting fair pricing, ensuring accessibility, and facilitating the equitable distribution of pharmaceutical products to enhance global health outcomes.
The ethical dimensions of pharmaceutical practices extend to the responsible marketing and promotion of drugs. This includes a commitment to accurate and unbiased promotional materials, coupled with ethical engagements with healthcare professionals to prevent undue influence. Upholding the highest standards of integrity is paramount for maintaining public trust and confidence in the industry.
Furthermore, pharmaceutical ethics delicately navigates the intersection of advancing scientific knowledge and safeguarding human rights. It acts as a moral compass, directing the industry toward practices that prioritize patient well-being, uphold integrity, and contribute positively to global health.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico